The largest database of trusted experimental protocols

70 protocols using tgf β1

1

Fibroblast-Macrophage Interaction and Myofibroblast Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Macrophages were co-cultured with 1 × 105 human primary dermal fibroblasts (ATCC, USA) within the matrix for 3 days in standard cell culture conditions. As negative and positive controls, 105 human primary dermal fibroblasts were cultured onto 3D collagen matrices with and without the presence of 10 ng/mL of transforming growth factor beta 1 (TGF-β1; Biolegend, USA). Afterwards, RNA was extracted and gene expression of myofibroblast markers was quantified using quantitative polymerase chain reaction (qPCR, see gene expression analysis section). Furthermore, as TGF-β1 is involved in the myofibroblast differentiation, we quantified the free active TGF-β1 in the cell culture supernatant using the TGF-β1 ELISA (enzyme-linked immunosorbent assay) kit (Biolegend, USA) following the protocol by the manufacturer. All experiments were undertaken in 4 replicates.
+ Open protocol
+ Expand
2

Naïve T Cell and Dendritic Cell Co-culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
For naïve T cell and DC co-cultures, naive CD4+ T cells (5 × 105 cells/mL) and DCs (5 × 105 cells/mL) were co-cultured in 96-well U-bottom plates and stimulated with soluble anti-CD3ε mAb (5 μg/mL) supplemented with 0.1 ng/mL TGF-β1 and 10 ng/mL IL-2 (BioLegend) for 3 days. For naïve T cell monocultures, naive CD4+ T cells (5 × 105 cells/mL) were cultured in 96-well flat-bottom high-binding plates (Corning). The cells were stimulated with immobilized anti-CD3ε mAb (5 μg/mL) and soluble anti-CD28 mAb (5 μg/mL) supplemented with 0.1 ng/mL TGF-β1 and 10 ng/mL IL-2 (BioLegend) for 3 days. LA, 10,13(OH)18:0, 17,18-DiHETE, 9,10-EpOME, 9,10-DiHOME, and 9,10-EpOME were purchased from Cayman Chemical Company and stored at -30 °C in methyl acetate before use. For all experiments, the methyl acetate was removed under a nitrogen steam. The compound was resuspended in TexMACS medium (Miltenyi Biotec) containing 20 µM GlutaMAX (Thermo Fisher Scientific), 55 µM 2-mercaptoethanol, 10 mM HEPES, 100 U/mL penicillin, and 100 µg/mL streptomycin, or RPMI 1640 medium containing 10% FBS, 20 µM GlutaMAX (Thermo Fisher Scientific), 55 µM 2-mercaptoethanol (Thermo Fisher Scientific), 10 mM HEPES, 100 U/mL penicillin, and 100 µg/mL streptomycin. The methyl formate fraction dissolved in ethanol was diluted in the culture medium at the same ethanol concentration (0.5%) under all dilution conditions.
+ Open protocol
+ Expand
3

Murine T Cell Differentiation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Differentiation of murine T cells was performed as previously described (40 (link)). Splenic T cells were isolated by magnetic activated cell sorting using the “pan T cell isolation kit II” according to the manufacturer’s instructions (Miltenyi Biotech). Cells were fluorescently stained with an antibody cocktail containing αCD4-FITC (RM4-5, eBioscience), αCD44-PE (IM7, Biolegend), αCD62L-APC (MEL-14, eBioscience), and αCD25-PE-Cy5 (PC61.5, eBioscience) and were subsequently isolated by fluorescence activated cell sorting on MoFlo (Beckman-Coulter, Brea, CA, USA) in the FACS-core unit of the University Hospital Erlangen. Sorted naive T cells (CD4+CD62L+CD44lowCD25) were stimulated by plate-bound anti-CD3 (2 µg/ml, 145-2C11, BD Pharmingen, San Diego, CA, USA) and soluble anti-CD28 (2 µg/ml, 37.51, BD Pharmingen) and cultured for 4 days in the presence of IL-6 (40 ng/ml, R&D Systems, Minneapolis, MN, USA) and TGFβ1 (2 ng/ml, Biolegend) for Th17, IL-12p70 (20 ng/ml,R&D Systems) and anti-IL-4 (10 µg/ml, Biolegend) for Th1 or TGFβ1 (10 ng/ml, Biolegend) alone for Treg differentiation. T cell frequencies were analyzed by flow cytometry (FACSCantoII, BD Biosciences) using the antibodies listed in the section “Murine FACS analysis.”
+ Open protocol
+ Expand
4

TGF-β1 Signaling Modulation in RCC Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
RCC cells were seeded in 100 mm cell culture dishes 24 h prior stimulation. For TGF-β1 stimulation, the cells were grown for 96 h in the presence of 10 ng/mL TGF-β1 (Biolegend, San Diego, CA, USA, Cat. No. 580704). For TGFBR1 inhibition, the cells were treated with 10 ng/mL SB 431542 (Sigma, St. Louis, MO, USA, CAS no. 301836-41-9) for 96 h. To refresh the stimulus or inhibitor, the medium was changed once after 48 h. For re-culture experiments, the cells were shifted to medium without TGF-β1 or DMEM supplemented with 10 ng/mL SB 431542 for 96 h after 96 h TGF-β1 treatment. Analogous, the medium was refreshed after 48 h. Untreated cells grown for the same period of time served as unstimulated controls.
+ Open protocol
+ Expand
5

Differentiation of Pathogenic Th17 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
1×106 CD4+ T cells were isolated and activated in 24 well-plates pre-coated with 10 μg/ml anti-CD3 (145–2C11, BioXCell) and 10 μg/ml anti-CD28 mAb (37.51, BioXCell) in serum-free X-VIVO 20 medium (Lonza). For pathogenic-Th17 cell differentiation, 20 ng/ml IL-1β (Biolegend), 40 ng/ml IL-6 (Biolegend), 50 ng/ml IL-23 (Biolegend) and 20 µg/ml anti-IFN-γ (XMG1.2, BioXcell) were added to the culture. For TGF-β1+IL-6 induced Th17 cell differentiation, 1 ng/ml TGF-β1 (Biolegend), 40 ng/ml IL-6 (Biolegend) and 20 µg/ ml anti-IFN-γ (XMG1.2, BioXcell) were added to the culture. For Activin-A+IL-6 promoted Th17 cells, 30ng/ml Activin-A (Biolegend), 40 ng/ml IL-6 (Biolegend) and 20µg/ml anti-IFN-γ mAb (XMG1.2, BioXcell) were added to the culture. Anti-Activin-A (clone 69403, R&D), anti-TGF-β1 (1D11, BioXcell), Follistatin (R&D) and MEK inhibitor PD98059 (Selleckchem) were added when needed as indicated in the figure legends. To assess proliferation, isolated CD4+ T Cells were labeled with 5 μM carboxyfluorescein diacetate succinimidyl ester (CFSE, AnaSpec) for 5 minutes at the room temperature. Labelled T cells were washed with PBS twice and activated under various conditions as indicated in the figure legends. The T cell proliferation was assessed 72 hours post activation based on CFSE dilution by flow-cytometry.
+ Open protocol
+ Expand
6

Inducing Epithelial-Mesenchymal Transition in HK-2 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
A human proximal renal tubular cell line (HK-2) was cultivated in a growth medium containing Dulbecco’s modified Eagle’s medium (DMEM) (Gibco, Grand Island, NY) supplemented with 10% inactivated fetal bovine serum (FBS) (Gibco) in the presence of 100 U/mL penicillin G and 100 mg/mL streptomycin (Sigma; St. Louis, MO). The cells were maintained in a humidified incubator at 37 °C with 5% CO2.
To induce EMT, HK-2 cells were seeded at a density of 5 × 104 cells/well in six-well plate and cultured in the growth medium for 24 h. The growth medium was then replaced with serum-free DMEM for 6 h followed by treatment with 5 ng/mL TGF-β1 (BioLegend, San Diego, CA) in a maintenance medium containing DMEM supplemented with 1% FBS for further 48 h. The cells without TGF-β1 treatment served as the control. Changes in cell morphology were observed under a phase-contrast microscope (Olympus CKX41; Olympus Co. Ltd, Tokyo, Japan). The cells were then subjected to endogenous peptide extraction and quantitative peptidomics analysis.
+ Open protocol
+ Expand
7

Chondrogenic Factors in MenSC-BMMSC Co-cultures

Check if the same lab product or an alternative is used in the 5 most similar protocols
TGF-β1, activin A, BMP-2, and IGF-1 protein production were evaluated during co-culture studies of MenSCs and BMMSCs, as well as MenSCs and cartilage explant co-cultures under inflammatory conditions with IL-1β (10 ng/mL). Supernatants were collected from the pellets incubated without growth factors during chondrogenic differentiation after 3, 7, and 21 days, and from explants after 21 days of incubation. TGF-β3-stimulated samples were not assessed in this study. Protein levels were detected using TGF-β1 (Biolegend), acitivin A (Abcam), BMP-2 (Abcam), and IGF-1 (Thermo Fisher Scientific) ELISA kits, according to manufacturer’s instructions. Protein levels secreted during co-cultures were normalized according to an upgrowing number of cells.
+ Open protocol
+ Expand
8

TGF-β1 Injection in Bleomycin-Induced OA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were injected intraperitoneally with 400 ng of recombinant TGF-β1 (BioLegend) three times, at 3, 6, and 9 days after BLM OA.
+ Open protocol
+ Expand
9

Cytokine Profiling of MSC Co-Cultures

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell culture supernatants collected from MSC and co-cultures were thawed
and tested for different cytokines using enzyme-linked immunosorbent assays.
IL-6, TNF-α, TGF-β1 (Biolegend, San Diego, CA, USA), and PGE2
(Cayman Chemical, Ann Arbor, MI, USA) were all measured according to the
manufacturer’s instructions. Absorbances were measured using a microplate
reader (DTX880 Multimode Detector, Beckman Coulter).
+ Open protocol
+ Expand
10

Murine and Human Th17 Cell Polarization

Check if the same lab product or an alternative is used in the 5 most similar protocols
For murine Th17 polarized culture, purified naive T cells were stimulated with plate-bound goat anti-hamster antibodies, soluble anti-CD3 Ab (0.25 μg/ml,145–2C11; Biolegend), anti-CD28 Ab (0.5 μg/ml, 37.51; Biolegend), IL-6 (10 ng/ml; R&D Systems), TGF-β1 (0.3 ng/ml; R&D Systems), anti-IL-4 Ab (10 μg/ml, C17.8; Biolegend), and anti-IFNγ Ab (10 μg/ml; XMG1.2; Biolegend). For the human Th17-polarized cultures, isolated naive CD4 T cells were stimulated with plate-bound anti-CD3 Ab (1 μg/ml, OKT-3; BioXCell), anti-CD28 Ab (1 μg/ml, CD28.2; Biolegend), IL-6 (50 ng/ml; # NM_000600; Biolegend), TGF-β1 (10 ng/ml, # NM_003236; Biolegend), IL-1β (10 ng/ml, # NM_000576; Biolegend), IL-23 (50 ng/ml, # NP_057668 and # NP_002178.2; Biolegend), anti-IL-4 Ab (10 μg/ml, MP4–25D2; BioXCell), and anti-IFNγ Ab (5 μg/ml; B27; BioXCell) (14 ). For the pharmacological Gls1 inhibition experiments, BPTES were diluted in 0.5 % DMSO and 10 mM BPTES or 0.5 % DMSO were administrated in the culture.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!